BioLineRx (BLRX) Capital Expenditures Growth (3y) (2016 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 46.88% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.97% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 16.27% |
| 10 | BioLineRx | 9.32 Bn | 9.30 Bn | 154,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 27.99% |
| Jun 30, 2024 | -12.43% |
| Mar 31, 2024 | -18.98% |
| Dec 31, 2023 | -162.07% |
| Dec 31, 2022 | -63.67% |
| Sep 30, 2022 | -128.94% |
| Jun 30, 2022 | -25.99% |
| Mar 31, 2022 | 16.57% |
| Dec 31, 2021 | 13.86% |
| Jun 30, 2021 | 4.77% |
| Mar 31, 2021 | 29.40% |
| Dec 31, 2020 | 26.08% |
| Dec 31, 2019 | -28.38% |
| Jun 30, 2019 | 6.60% |
| Mar 31, 2019 | 39.06% |
| Dec 31, 2018 | 23.54% |
| Jun 30, 2018 | 75.17% |
| Mar 31, 2018 | 28.70% |
| Dec 31, 2017 | -94.76% |
| Sep 30, 2017 | 34.62% |
| Jun 30, 2017 | -3.15% |
| Mar 31, 2017 | 1.44% |
| Dec 31, 2016 | 78.98% |
| Jun 30, 2016 | -2.60% |
| Mar 31, 2016 | -131.80% |